Bioinformatics Engineer – Operations
PathoQuest is a specialized service company (CRO), a spin off of the Institut Pasteur, which offers innovative solutions for the Quality Control of pharmaceutical products of biological origin. PathoQuest offers biotech innovators around the world a complete expert service from receipt of samples to the production of certificates of analysis. Its assays use proprietary sample processing protocols, a Next Generation Sequencing (NGS) sequencing platform and specialized bioinformatics analysis pipelines.
We are currently looking for a Bioinformatics Engineer with our Operations department.
Your mission
Within the Operations department, under the responsibility of the Head of Bioinformatics, you ensure the follow-up, execution and timely reporting of bioinformatics analyzes of data produced by the company’s sequencing platforms, mainly those that relate to viral safety and genetic characterization services.
-
Participate in the production activities of the company and their evolutions
-
Perform internal and external customer analyzes
-
Follow the company’s quality approach during the design, development and deployment phases of bioinformatics software products, in particular by writing the associated documents (functional specifications, test book)
-
Ensure an effective technological watch in bioinformatics
-
Participate in product quality assurance according to the Good Manufacturing Practices (GMP) standard
Profile
Training in bioinformatics, you have experience on a similar function on Illumina or Nanopore.
You master bioinformatics development languages such as Python and R.
You are comfortable working in a Linux environment and on high performance computing servers.
You know how to analyze high-throughput sequencing data and interpret the results.
Technical skills:
- De Novo & Guided Assembly, Mapping, Linux, NCBI, NGS, Blast
- Ensure an effective technological watch in bioinformatics
- Knowledge of biology (molecular and cellular biology, genomics and genetics).
- Knowledge of GMP quality standards.
- A good level of English is a plus.
- Ability to work in a team and at the interface between several disciplines
- Excellent rigor in process monitoring
- Curiosity and interest in rapidly changing fields
- Interpersonal skills and adaptability autonomy and sense of initiative
Location
This position is based near the Paris office (13th arrondissement) in France
Remuneration
Depending on the experience of the candidate
The benefits of the project
- Growing environment, dynamic, innovative and ambitious start-up
- A company at the forefront of genetics, bioinformatics and molecular biology
- Attractive and world-class customer portfolio
We thank those interested in this position and who meet the above criteria to send us their resume at careers@pathoquest.com
News & Events
PathoQuest CEO Jean-François Brepson, Featured on Molecule to Market Podcast
PathoQuest CEO Jean-François Brepson joins the Molecule to Market podcast to share his journey from pharma leader to CRO entrepreneur, discussing innovation, strategic partnerships, and how NGS is reshaping modern quality control.
FDA Announces Plan to Phase Out Animal Testing Requirement for mAbs and Other Drugs
The FDA announced a plan to phase out animal testing requirements for monoclonal antibodies and other drugs, reinforcing the 3R principles: Replace, Reduce, Refine. It encourages alternative methods to speed up drug development and cut costs. At PathoQuest, our animal-free GMP NGS platform supports viral safety testing without animals, accelerates QC timelines, and helps biopharma prepare for evolving regulatory expectations.
A NEW publication from a study conducted by AVDTWG and the FDA confirms NGS as a reliable technology for Adventitious Virus Detection
𝐍𝐄𝐖 𝐏𝐔𝐁𝐋𝐈𝐂𝐀𝐓𝐈𝐎𝐍: A comparative study conducted by members of the Advanced Virus Detection Technologies Working Group (𝐀𝐕𝐃𝐓𝐖𝐆), including participants from industry, contract research organizations (CROs), and the FDA, has been published in npj Vaccines. This study assessed the ability of Next-Generation Sequencing (NGS) to detect low levels of viral particles in a high-titer virus stock.
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
Sign up for our latest news
Follow Us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
Sign up for our latest news
Follow Us
How can PathoQuest help?
